Home > Boards > US Listed > Medical - Drugs >

Tekmira Pharmaceuticals Corporation (TKMR)

Add TKMR Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator mick, nanopatent, KarinCA
Search This Board:
Last Post: 7/1/2015 3:25:57 PM - Followers: 115 - Board type: Free - Posts Today: 0

Tekmira Pharmaceuticals Corporation








Company Information:

100 - 8900 Glenlyon Parkway
Burnaby, British Columbia
Canada V5J 5J8

Telephone: 604.419.3200
Fax: 604.419.3201


As the fields of genetics, medicine and therapeutics continue to converge, the management of illness at its genetic source by silencing genes via RNA interference (RNAi) holds the very real potential to revolutionize treatment on a scale not seen in decades. Tekmira is one of a handful of biotech companies around the world working to exploit the potential of RNAi to treat disease. And it is from among these unique companies that the next wave of therapeutic breakthroughs will emerge.

 Tekmira is uniquely equipped to become a leading force in the field. Guided by a cohesive vision, the company possesses leading technology capabilities and a solid intellectual property portfolio in the area of lipid-based nucleic acid delivery, known as SNALP (Stable Nucleic Acid Lipid Particles) to deliver siRNAs (small interfering RNAs) as well as other oligonucleotides in the treatment of disease.

With one RNAi drug candidate in clinical development and another in late preclinical development,  plus a pipeline of up to five additional targets made possible through an agreement with RNAi leader Alnylam, Tekmira is well positioned to aggressively advance its product development strategy. In addition to Alnylam, Roche, Merck and Regulus all have access to Tekmira's technology in the delivery of siRNAs and microRNAs.

Finally, broad manufacturing capabilities and a strong capital position permit the company to move forward decisively and build a solid base for both near and longer term growth.




Important Company Highlights: 

LNP Delivery Platform

Tekmira’s Lipid Nanoparticle (LNP) technology represents the most widely adopted RNAi delivery technology to date. Administered intravenously, our LNP delivery technology allows RNAi drugs to be encapsulated in tiny particles made of lipids (fats or oils). These tiny particles – LNP – travel through the bloodstream to target tissues.





Recent News:





Links of importance for those that trade Canadian stocks:




 CNW Group Newswire:

Canadian Insider:

Currency Converter:


Transfer Agent:

CIBC Mellon Trust,
Suite 1600, The Oceanic Plaza,
1066 West Hastings Street,
Vancouver, BC V6E 3X1

Share Structure:   See filings

Investor Relations:

Ian Mortimer
Executive Vice President, Finance and Chief Financial Officer
Telephone: 604.419.3200
Fax: 604.419.3201

Adam Peeler
Investor Relations
The Equicom Group
Telephone: 416.815.0700 x 225 

 Currency Converter:





 All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.

 Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
Option Chain for TKMR
TKMR News: Current Report Filing (8-k) 06/19/2015 08:01:11 AM
TKMR News: Current Report Filing (8-k) 06/18/2015 08:01:21 AM
TKMR News: Revised Proxy Soliciting Materials (definitive) (defr14a) 06/05/2015 03:52:14 PM
TKMR News: Proxy Statement (definitive) (def 14a) 05/29/2015 04:42:08 PM
TKMR News: Current Report Filing (8-k) 05/21/2015 05:12:30 PM
#1088  Sticky Note TKMR – Tekmira Pharmaceuticals Corp News, Filings and misc: KarinCA 08/10/14 01:52:25 AM
#4924   ......a trend remains a trend until it is wsgalvanize 07/01/15 03:25:57 PM
#4923   Tekmira Pharmaceutic (TKMR) mick 07/01/15 03:20:55 PM
#4922 that doesn't look good at all...thanks for wsgalvanize 07/01/15 01:20:19 PM
#4921 mick 06/30/15 06:48:44 PM
#4920   IMO there are investors, related or not to Ron1303 06/26/15 10:47:11 AM
#4919 thuber 06/26/15 12:40:17 AM
#4918   Just for the hellovit I looked up Tekmira's nanopatent 06/23/15 01:38:15 PM
#4917   Even when there was a lot less doubt Ron1303 06/23/15 01:24:52 PM
#4916   You know what the main killer of a nanopatent 06/23/15 12:53:46 PM
#4915   I don´t think TKMR management is "confused". Ron1303 06/23/15 11:02:12 AM
#4914   I always expect management to know much more nanopatent 06/22/15 11:00:05 PM
#4913   First of all, we don't know the full KarinCA 06/22/15 10:35:51 PM
#4912   True. And yet it failed miserably in human studies. nanopatent 06/22/15 10:32:50 PM
#4911   I don't agree. TKM-ebola did very well KarinCA 06/22/15 10:28:40 PM
#4910   I kinda get the feeling Tekmira knew TKM-Ebola nanopatent 06/22/15 10:20:57 PM
#4909   What Does the Future Hold for Tekmira’s Ebola Program? KarinCA 06/22/15 08:18:36 PM
#4908   The Welcome news points to lack of success Echo20 06/21/15 11:02:48 AM
#4907   The Helen Branswell - TORONTO — The Canadian Ron1303 06/20/15 07:23:18 PM
#4906   Nanopstemt Short and come back Echo 20 Echo20 06/20/15 05:13:13 PM
#4905   Nanopatent From the PRS was there any success mentioned,? Any Echo20 06/20/15 05:05:11 PM
#4904 mick 06/20/15 02:16:09 PM
#4903   Trial of Tekmira's Ebola drug stopped; no overall nanopatent 06/20/15 10:06:32 AM
#4902   Who knows! nanopatent 06/20/15 10:03:54 AM
#4901   Nano patent The trial data is being analyses. The results Echo20 06/20/15 10:02:18 AM
#4900   Tekmira stops adding new patients to study of nanopatent 06/20/15 09:46:33 AM
#4899   Canadian company halts Ebola drug testing in Sierra Leone nanopatent 06/20/15 09:35:59 AM
#4898   Trial of Canadian Ebola drug stopped after no nanopatent 06/19/15 08:48:54 PM
#4897   Tekmira Tumbles On Ominous Signs For Ebola Drug nanopatent 06/19/15 08:34:29 PM
#4896   Researchers Put Brakes on Study of Tekmira Ebola nanopatent 06/19/15 08:28:45 PM
#4895   Tekmira: With Its Ebola Drug Gone, Is It nanopatent 06/19/15 08:11:56 PM
#4894   Here's what I think - the PR is nanopatent 06/19/15 04:38:32 PM
#4893   The market knows, or so I have always nanopatent 06/19/15 04:23:06 PM
#4892   Hello Karin. Also begs the questions: Ron1303 06/19/15 03:14:44 PM
#4891   The pr was poorly written. I agree KarinCA 06/19/15 03:02:38 PM
#4890   A stitch in time saves 9. Ron1303 06/19/15 02:54:14 PM
#4889   The market thought like you did initially - negative. nanopatent 06/19/15 02:48:23 PM
#4888   I hope you are right, Ron1303 06/19/15 02:45:30 PM
#4887   What it means, to me, is there is nanopatent 06/19/15 02:42:22 PM
#4886   Post by mcmc at investor village re the wording: Ron1303 06/19/15 02:26:31 PM
#4884   charged with failure innuendoHow so? nanopatent 06/19/15 11:31:37 AM
#4883   Contrary to the clear 4/22 PR with the Ron1303 06/19/15 10:34:31 AM
#4882   And soldier - just was it that led nanopatent 06/16/15 08:22:37 PM
#4881   Nano patent TKMR needs results in Africa on Ebola Echo20 06/16/15 06:30:05 PM
#4880   New Ebola cases in Sierra Leone... Dreadker 06/15/15 03:05:11 PM
#4879   Nano, I don´t know if Hocuslocus will help nanopatent 06/15/15 02:20:52 PM
#4878   Nano, I don´t know if Hocuslocus will help Ron1303 06/15/15 01:31:56 PM
#4877   Is HOCUSLOCUS going to help or hinder Tekmira? nanopatent 06/15/15 01:10:50 PM
#4876   TKMR as I see it Ron1303 06/15/15 01:05:22 PM
#4875   5 Gs great. nanopatent 06/11/15 09:21:56 PM
#4874   great day today. Glad I picked up shares Tuesday. rivervalley 06/11/15 03:57:18 PM